NCCN Guidelines® Insights: Melanoma: Cutaneous, Version 2.2024

2024104 citationsJournal Article

Authors

Susan M. Swetter · Stanford Cancer Institute

Douglas B. Johnson · Breast Cancer Research Foundation

Mark R. Albertini · University of Wisconsin Carbone Cancer Center

Christopher A. Barker · Memorial Sloan Kettering Cancer Center

Sarah B. Bateni · O'Neal Comprehensive Cancer Center

Joel Baumgartner · UC San Diego Health System

Shailender Bhatia

Abstract

The NCCN Guidelines for Cutaneous Melanoma (termed Melanoma: Cutaneous) provide multidisciplinary recommendations for diagnostic workup, staging, and treatment of patients. These NCCN Guidelines Insights focus on the update to neoadjuvant systemic therapy options and summarize the new clinical data evaluated by the NCCN panel for the recommended therapies in Version 2.2024 of the NCCN Guidelines for Cutaneous Melanoma.

Topics & Keywords

CAR-T cell therapy research Cutaneous Melanoma Detection and Management Melanoma and MAPK Pathways

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Journal of the National Comprehensive Cancer Network

Volume 22, Issue 5, pp. 290-298

DOI: 10.6004/jnccn.2024.0036

Field-Weighted Citation Impact: 29.66